Adenoid cystic carcinoma (ACC) is a rare cancer with high potential for recurrence and
metastasis. Efficacy of current treatment options, particularly for advanced disease, is very …

More than 70 benign and malignant sinonasal tumours and tumour-like conditions have
been described. However, sinonasal tumours are rare, and sinonasal cancers comprise only …

Simple Summary Adenoid cystic carcinoma (ACC) is a salivary malignancy known for slow
growth, a propensity for perineural spread, local recurrence following resection, and indolent …

BACKGROUND: The scientific literature to date lacks population‐based studies on the
demographics, clinical features, and survival of patients with adenoid cystic carcinoma …

Objectives: This study provides an up-to-date overview of the distribution of salivary gland
tumors in relation to sex, land of treatment, localization of the tumor in the mouths, and …

The incidence of recurrent t (6; 9) translocation of the MYB proto‑oncogene to NFIB (the
gene that encodes nuclear factor 1 B‑type) in adenoid cystic carcinoma (ACC) tumour …

Introduction Adenoid cystic carcinoma (AdCC) is a rare tumour as it accounts for about 10%
of all salivary gland neoplasms. It occurs in all age groups with a predominance of women …

Salivary gland cancers are an incredibly heterogeneous group of tumors that include 24
histologically distinct tumor types. The use of new genetic methods has paved the way for …

Background: Apatinib, a vascular endothelial growth factor receptor (VEGFR) blocker, has
demonstrated encouraging antitumor activities and tolerable toxicities in various cancer …

Background: Intraoral adenoid cystic carcinoma (ACC) arising from minor salivary glands
(MSG) is a rare malignancy associated with delayed diagnosis and unfavorable outcomes …